Compound News and Research

RSS

Machine learning model predicts chemical reactions to accelerate drug discovery

Drug discovery is like molecular Tetris. Chemists snap atoms together, adjusting the pieces until everything fits and suddenly, a molecule makes a promising new medicine.

9 Mar 2026

Modified psilocybin compounds may treat brain disorders with fewer hallucinations

Psilocybin - the psychoactive compound in "magic mushrooms" - is gaining scientific attention for its potential in treating neuropsychiatric conditions including depression, anxiety, substance use disorders and certain neurodegenerative diseases.

6 Mar 2026

PET imaging reveals molecular mechanism behind ketamine's antidepressant effects

Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and approximately 30% of patients develop treatment-resistant depression (TRD), a condition that does not respond adequately to conventional antidepressant therapies.

6 Mar 2026

New compound shows promise in protecting the liver from damage after small bowel surgery

When parts of the small intestine are diseased or die, the treatment can involve surgically removing the affected tissue.

6 Mar 2026

MSU scientists map the neural circuitry of drug compulsion

When a cocaine addict relapses, it isn't a matter of personal failure - it's the biological result of their brain's rewiring, new research finds.

5 Mar 2026

Polystyrene nanoplastics influence Salmonella survival and antibiotic resistance

Plastic products are ubiquitous in our food supply chain, shedding microplastics into every part of the human ecosystem.

27 Feb 2026

Promega unveils cellular target engagement technology aimed at expanding the druggable proteome at SLAS 2026

Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins.

From Promega Corporation 27 Feb 2026

Neem compound gedunin shows promise against pancreatic cancer

Ramadevi Subramani Reddy, Ph.D., remembers the neem tree from her childhood in India - a plant her grandmother used to treat everything from fevers to infections.

26 Feb 2026

Novel lipid bubble delivery shows promise for ALS treatment

A researcher at the University of Missouri has made a promising breakthrough in the quest to help people with amyotrophic lateral sclerosis (ALS), the neurodegenerative disorder commonly known as Lou Gehrig's disease.

26 Feb 2026

Middle-aged men most vulnerable to aging effects of new PFAS

Per- and polyfluoroalkyl substances (PFAS) – 'forever chemicals' in common parlance – are a class of thousands of synthetic chemicals often used in non-stick coatings, water-resistant fabrics, fire-fighting foams, food packages, cleaning products, and plastics.

26 Feb 2026

Phase 2 clinical trial tests LMP744 for the treatment of first-time recurrent glioblastoma

Gibson Oncology, a clinical-stage private pharmaceutical company headquartered in Miami, announced it has entered Phase 2 clinical trials with LMP744 for the treatment of first-time recurrent glioblastoma patients.

25 Feb 2026

Automated platform finds unexpected enhancers for mRNA therapeutics

Integrating AI with advanced robotics to create self-driving labs (SDL) is a promising approach to tackling molecular discovery.

24 Feb 2026

Centauri Therapeutics extends Series A to £30 M with £6 M investment from AMR Action Fund to support progression of lead clinical candidate

Centauri Therapeutics Limited ('Centauri'), an immunotherapy company with a unique and proprietary platform technology applicable across a wide range of therapeutic indications, today announced it has secured £6 M from AMR Action Fund, extending the Company's Series A round to £30 M.

24 Feb 2026

Natural compound from pomegranate leaves shows promise against TTR amyloidosis

A research team in Kumamoto University has discovered that a natural compound found in pomegranate leaves and branches can directly break down harmful protein aggregates linked to transthyretin (TTR) amyloidosis, a progressive and potentially life-threatening disease affecting the nerves and heart.

23 Feb 2026

NUS scientists transform kombu into a probiotic superfood with fruity aromas

Kombu (Saccharina japonica) is a brown seaweed extensively cultivated and consumed in Japan, Korea and China. Despite its nutritional value, its strong fishy and grassy odor can deter some consumers.

23 Feb 2026

Scientists reveal how the body senses cold and menthol

When you step outside on a winter morning or pop a mint into your mouth, a tiny molecular sensor in your body springs into action, alerting your brain to the sensation of cold.

22 Feb 2026

Neutral polymer enables safer DNA delivery into cells

Researchers from Tokyo Metropolitan University have created a new molecule which carries DNA into biological cells, to treat or vaccinate against illnesses.

22 Feb 2026

Loose clothing sensors enhance clinical movement tracking

Loose-fitting e-textiles may offer superior motion tracking capabilities, enhancing recognition accuracy and prediction over conventional rigid sensors.

19 Feb 2026

How GLP-1 drugs affect the body beyond weight loss and glucose control

This review evaluates the safety profile of glucagon-like peptide-1 receptor agonists and related incretin therapies used for obesity and type 2 diabetes. It highlights common gastrointestinal effects, rare but debated risks, and areas where further long-term safety data are still needed.

18 Feb 2026

Oral weight loss ingredient may have adverse biological effects for the gut and beyond

A new study from Adelaide University is turning a spotlight on those tablet versions, finding that the absorption-enhancing ingredient salcaprozate sodium (SNAC) may have measurable adverse biological effects for the gut and beyond.

17 Feb 2026

Compound News and Research

Machine learning model predicts chemical reactions to accelerate drug discovery

Modified psilocybin compounds may treat brain disorders with fewer hallucinations

PET imaging reveals molecular mechanism behind ketamine's antidepressant effects

New compound shows promise in protecting the liver from damage after small bowel surgery

MSU scientists map the neural circuitry of drug compulsion

Polystyrene nanoplastics influence Salmonella survival and antibiotic resistance

Promega unveils cellular target engagement technology aimed at expanding the druggable proteome at SLAS 2026

Neem compound gedunin shows promise against pancreatic cancer

Novel lipid bubble delivery shows promise for ALS treatment

Middle-aged men most vulnerable to aging effects of new PFAS

Phase 2 clinical trial tests LMP744 for the treatment of first-time recurrent glioblastoma

Automated platform finds unexpected enhancers for mRNA therapeutics

Centauri Therapeutics extends Series A to £30 M with £6 M investment from AMR Action Fund to support progression of lead clinical candidate

Natural compound from pomegranate leaves shows promise against TTR amyloidosis

NUS scientists transform kombu into a probiotic superfood with fruity aromas

Scientists reveal how the body senses cold and menthol

Neutral polymer enables safer DNA delivery into cells

Loose clothing sensors enhance clinical movement tracking

How GLP-1 drugs affect the body beyond weight loss and glucose control

Oral weight loss ingredient may have adverse biological effects for the gut and beyond

Advancing therapeutic biopolymer development eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News